PortfoliosLab logo
PortfoliosLab logo
Tools
Performance Analysis
Portfolio Analysis
Factor Model
Portfolios
Lazy PortfoliosUser Portfolios
Discussions
IDYA vs. RXST
Performance
Risk-Adjusted Performance
Dividends
Drawdowns
Volatility
Financials

Key characteristics


IDYARXST
YTD Return5.28%36.31%
1Y Return27.03%85.18%
3Y Return (Ann)14.17%61.70%
Sharpe Ratio0.621.56
Daily Std Dev45.91%54.94%
Max Drawdown-74.64%-48.21%
Current Drawdown-20.52%-14.51%

Fundamentals


IDYARXST
Market Cap$3.16B$2.18B
EPS-$2.26-$0.99
Total Revenue (TTM)$11.96M$123.65M
Gross Profit (TTM)$7.77M$76.32M
EBITDA (TTM)-$189.27M-$37.74M

Correlation

-0.50.00.51.00.3

The correlation between IDYA and RXST is 0.28, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.

Performance

IDYA vs. RXST - Performance Comparison

In the year-to-date period, IDYA achieves a 5.28% return, which is significantly lower than RXST's 36.31% return. The chart below displays the growth of a $10,000 investment in both assets, with all prices adjusted for splits and dividends.


-20.00%-10.00%0.00%10.00%20.00%30.00%40.00%AprilMayJuneJulyAugustSeptember
-13.81%
17.54%
IDYA
RXST

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Risk-Adjusted Performance

IDYA vs. RXST - Risk-Adjusted Performance Comparison

This table presents a comparison of risk-adjusted performance metrics for IDEAYA Biosciences, Inc. (IDYA) and RxSight, Inc. (RXST). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


IDYA
Sharpe ratio
The chart of Sharpe ratio for IDYA, currently valued at 0.62, compared to the broader market-4.00-2.000.002.000.62
Sortino ratio
The chart of Sortino ratio for IDYA, currently valued at 1.16, compared to the broader market-6.00-4.00-2.000.002.004.001.16
Omega ratio
The chart of Omega ratio for IDYA, currently valued at 1.14, compared to the broader market0.501.001.502.001.14
Calmar ratio
The chart of Calmar ratio for IDYA, currently valued at 0.97, compared to the broader market0.001.002.003.004.005.000.97
Martin ratio
The chart of Martin ratio for IDYA, currently valued at 2.25, compared to the broader market-10.00-5.000.005.0010.0015.0020.002.26
RXST
Sharpe ratio
The chart of Sharpe ratio for RXST, currently valued at 1.56, compared to the broader market-4.00-2.000.002.001.56
Sortino ratio
The chart of Sortino ratio for RXST, currently valued at 2.37, compared to the broader market-6.00-4.00-2.000.002.004.002.37
Omega ratio
The chart of Omega ratio for RXST, currently valued at 1.28, compared to the broader market0.501.001.502.001.28
Calmar ratio
The chart of Calmar ratio for RXST, currently valued at 2.30, compared to the broader market0.001.002.003.004.005.002.30
Martin ratio
The chart of Martin ratio for RXST, currently valued at 6.41, compared to the broader market-10.00-5.000.005.0010.0015.0020.006.41

IDYA vs. RXST - Sharpe Ratio Comparison

The current IDYA Sharpe Ratio is 0.62, which is lower than the RXST Sharpe Ratio of 1.56. The chart below compares the 12-month rolling Sharpe Ratio of IDYA and RXST.


Rolling 12-month Sharpe Ratio1.002.003.004.005.00AprilMayJuneJulyAugustSeptember
0.62
1.56
IDYA
RXST

Dividends

IDYA vs. RXST - Dividend Comparison

Neither IDYA nor RXST has paid dividends to shareholders.


Tickers have no history of dividend payments

Drawdowns

IDYA vs. RXST - Drawdown Comparison

The maximum IDYA drawdown since its inception was -74.64%, which is greater than RXST's maximum drawdown of -48.21%. Use the drawdown chart below to compare losses from any high point for IDYA and RXST. For additional features, visit the drawdowns tool.


-40.00%-30.00%-20.00%-10.00%0.00%AprilMayJuneJulyAugustSeptember
-20.52%
-14.51%
IDYA
RXST

Volatility

IDYA vs. RXST - Volatility Comparison

IDEAYA Biosciences, Inc. (IDYA) and RxSight, Inc. (RXST) have volatilities of 10.28% and 10.24%, respectively, indicating that both stocks experience similar levels of price fluctuations. This suggests that the risk associated with both stocks, as measured by volatility, is nearly the same. The chart below showcases a comparison of their rolling one-month volatility.


10.00%15.00%20.00%AprilMayJuneJulyAugustSeptember
10.28%
10.24%
IDYA
RXST

Financials

IDYA vs. RXST - Financials Comparison

This section allows you to compare key financial metrics between IDEAYA Biosciences, Inc. and RxSight, Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities



Values in USD except per share items